The Federal Trade Commission will hold a public workshop June 18 in Washington, D.C., to assess the impact of certificates of public advantage on health care prices, quality, access and innovation. “States have enacted COPAs with the assumption that regulatory oversight can mitigate the effects of lost competition and may allow hospitals to achieve certain efficiencies,” FTC said. “The Commission is interested in empirical research on the actual benefits and harms associated with COPAs, and on qualitative analyses of stakeholders’ experience with COPAs. Such studies and analyses, as well as the information presented at this workshop, may help advance the agency’s policy and enforcement strategies.” The workshop is part of FTC’s COPA Assessment Project.

Related News Articles

Headline
The Health Resources and Services Administration Aug. 20 announced  $1.4 billion in program funding for individuals with HIV who have low incomes to…
Headline
Two clinicians and a vehicle — that's the model Sheppard Pratt has been using to give behavioral health access to its communities. In this conversation, Jason…
Headline
The Centers for Medicaid and Medicare Services Aug. 20 released a report presenting data on complaints and enforcement efforts by the agency concerning title…
Headline
The White House this week announced plans to improve health insurance for consumers, with a particular focus on easing claims and appeals processes. In a…
Headline
More than 46 million prior authorization requests were submitted to Medicare Advantage insurers in 2022, according to KFF analysis released Aug. 6 examining…
Headline
UnitedHealth Group Aug. 1 announced the creation of a gold card program for qualified practices. Under the program, the practices that earn gold card status…